查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566952

胆红素计市场：按产品、适应症、年龄层和最终用户：2024-2033 年全球机会分析和产业预测

Bilirubin Meters Market By Product , By Indication By Age Group By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年胆红素测量仪器市场价值为12亿美元，预计2024年至2033年复合年增长率为7.6%，到2033年将达到25亿美元。

胆红素测定仪是一种手持式医疗设备，主要用于测量新生儿血胆红素浓度。胆红素水平升高会导致黄疸，黄疸是婴幼儿的常见病症，如果不及时治疗，可能会导致严重的健康问题，包括脑损伤。这些仪器提供了一种非侵入性、快速且准确的方法来监测胆红素水平，从而实现早期检测和治疗。因此，它们在新生儿护理中发挥着重要作用，帮助医疗保健专业人员就是否需要进一步检查和干预措施做出明智的决定。

全球胆红素检测仪市场的成长是由于新生儿黄疸盛行率的惊人上升以及对新生儿黄疸的早期诊断和治疗以预防马苏等併发症的日益重视所推动的。根据 Science Direct 2024 年 1 月发表的一项研究，全球每年约有 110 万名新生儿患有高胆红素血症，超过 2,000 万名新生儿面临高胆红素血症相关併发症的风险。此外，容易患黄疸的早产儿数量不断增加，也增加了对胆红素测量设备的需求。这是因为胆红素计在新生儿加护病房中至关重要，因为早产儿通常需要更密切的监测。根据世界卫生组织 (WHO) 统计，2020 年约有 1,340 万名早产儿。此外，旨在降低婴幼儿死亡率和改善新生儿健康的政府措施不断增多，正在推动胆红素测量设备的采用，这是全球市场的主要驱动力。使用经皮方法透过皮肤测量胆红素水平的非侵入性胆红素测量设备的转变是当前的趋势，正在加强全球市场的成长。这些设备减少了抽血的需要，减轻了新生儿的抽血压力，并提高了医疗保健提供者的效率。儘管非侵入式数位胆红素测量仪具有显着的优点，但其高成本对采用造成了障碍，特别是在低收入地区和小型医疗机构，从而阻碍了市场的成长。此外，医疗保健专业人员缺乏对定期胆红素监测和使用胆红素测量设备的重要性的认识和培训，这是市场的主要阻碍因素。为此，製造商正在专注于开发可携式和现场胆红素测量仪，这些测量仪结构紧凑、易于使用，并且设计用于各种环境，包括医院、诊所，甚至是我正在做的居家医疗。它。此外，感测器技术的创新使得胆红素测量仪器变得更加准确和可靠。这些进步包括使用频谱感测器和演算法，即使是深色皮肤的婴儿也能进行精确测量，解决了旧设备先前的局限性。此类新兴市场的开拓预计将为市场成长提供有利可图的机会。

全球胆红素测量仪器产业按产品、适应症、年龄层、最终用户和地区细分。依产品划分，市场分为台式和经皮型。从适应症来看，可分为黄疸型和肝炎型。依年龄组，分为新生儿和成人。依最终用户划分，可分为医院/护理机构、诊所等。按地区划分，对北美、欧洲、亚太地区和拉丁美洲地区市场进行了分析。

主要发现

从产品来看，经皮领域将在 2023 年占据市场占有率。

有迹象表明，黄疸板块是2023年的主要股东。

按年龄组别划分，新生儿成为 2023 年的关键群体。

从最终用户来看，医院和护理机构已成为 2023 年的主要细分市场。

按地区划分，北美在 2023 年获得最大份额，而亚太地区预计在预测期内复合年增长率最高。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章胆红素计市场：副产品

  • 市场概况
  • 桌上型
  • 经皮的

第五章胆红素计市场：依指标分类

  • 市场概况
  • 黄疸
  • 肝炎

第六章胆红素计市场：依年龄组

  • 市场概况
  • 新生
  • 成人

第七章胆红素测量仪器市场：依最终用户分类

  • 市场概况
  • 医院及疗养院
  • 诊所
  • 其他的

第八章胆红素测量仪器市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国胆红素测量仪器市场
    • 加拿大胆红素测量仪器市场
    • 墨西哥胆红素测量仪器市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国胆红素测量仪器市场
    • 法国胆红素仪市场
    • 英国胆红素测定仪市场
    • 义大利胆红素测定仪市场
    • 西班牙胆红素测定仪市场
    • 其他欧洲国家胆红素测量仪器市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本胆红素测量仪器市场
    • 中国胆红素测量仪器市场
    • 澳洲胆红素计市场
    • 印度胆红素测定仪市场
    • 韩国胆红素测量仪器市场
    • 其他亚太胆红素测量仪器市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西胆红素测量仪器市场
    • 沙乌地阿拉伯胆红素测量仪市场
    • 南非胆红素测量仪器市场
    • 其他拉丁美洲/中东/非洲胆红素测量仪器市场

第9章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第十章 公司简介

  • APEL Co. Ltd
  • Dragerwerk AG And Co. KGaA
  • Mennen Medical Ltd
  • Micro Lab Instruments
  • Ningbo David Medical Device Co. Ltd
  • Siemens Healthineers AG
  • Micro Labs Instruments
  • AVI Healthcare Pvt Ltd
  • F. Hoffmann-La Roche Ltd.
  • Koninklijke Philips NV
简介目录
Product Code: A324070

The bilirubin meters market was valued at $1.2 billion in 2023, and is projected to reach $2.5 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

Bilirubin meter is a handheld medical device designed to measure the levels of bilirubin in the blood, primarily in newborns. Elevated bilirubin levels can lead to jaundice, a common condition in infants that, if left untreated, can cause serious health issues, including brain damage. These meters provide a non-invasive, quick, and accurate method for monitoring bilirubin levels, enabling early detection and treatment. Thus, they play a critical role in neonatal care, helping healthcare professionals make informed decisions about the need for further testing or interventions.

The growth of the global bilirubin meters market is driven by alarming rise in prevalence of neonatal jaundice and increase in emphasis on early diagnosis and treatment of jaundice in newborns to prevent complications such as kernicterus. According to a study published by Science Direct in January 2024, approximately 1.1 million babies worldwide develop hyperbilirubinemia yearly; over 20 million are at risk of hyperbilirubinemia-related complications. Furthermore, rise in the number of preterm births, which are more susceptible to jaundice, is contributing to the demand for bilirubin meters. This is attributed to the fact that premature infants often require closer monitoring, making bilirubin meters essential in neonatal intensive care units. As per the World Health Organization, approximately 13.4 million preterm births were reported in 2020. Furthermore, rise in government initiatives aimed at reducing infant mortality and improving neonatal health is encouraging the adoption of bilirubin meters, which acts as the key driving force of the global market. Shift toward non-invasive bilirubin meters, which measure bilirubin levels through the skin using transcutaneous methods, is the current trend that is strengthening the growth of the global market. These devices reduce the need for blood draws, making the process less stressful for newborns and more efficient for healthcare providers. Although non-invasive and digital bilirubin meters offer significant benefits, their high cost can be a barrier to adoption, particularly in low-income regions and smaller healthcare facilities, thereby hampering the market growth. In addition, lack of awareness and training among healthcare providers regarding the importance of regular bilirubin monitoring and the use of bilirubin meters acts as a key deterrent factor of the market. On the contrary, manufacturers are focusing on the development of portable and point-of-care bilirubin meters, which are compact, easy to use, and designed for use in various settings, including hospitals, clinics, and even in-home care. Furthermore, innovations in sensor technology are leading to more accurate and reliable bilirubin meters. These advancements include the use of multispectral sensors and algorithms that provide precise measurements, even in infants with darker skin tones, addressing previous limitations of older devices. Such developments are expected to offer lucrative opportunities for the market growth.

The global bilirubin meters industry is segmented into product, indication, age group, end user, and region. By product, the market is divided into bench-top and transcutaneous. On the basis of indication, it is segregated into jaundice and hepatitis. As per age group, it is classified into neonatal and adults. Depending on end user, it is segregated into hospitals & nursing home, clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the transcutaneous segment dominated the market share in 2023.

On the basis of indication, the jaundice segment was the major shareholder in 2023.

As per age group, neonatal emerged as the leading segment in 2023.

Depending on end user, hospitals & nursing home emerged as the leading segment in 2023.

Region wise, North America garnered maximum share in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bilirubin meters market include APEL Co. Ltd., Dragerwerk AG & Co. KGaA, Mennen Medical Ltd, Micro Lab Instruments, Ningbo David Medical Device Co. Ltd., Siemens Healthineers AG, Micro Labs Instruments, AVI Healthcare Pvt Ltd, F. Hoffmann-La Roche Ltd., and Koninklijke Philips N.V. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

By Product

  • Bench-Top
  • Transcutaneous

By Indication

  • Jaundice
  • Hepatitis

By Age Group

  • Neonatal
  • Adults

By End User

  • Hospitals and Nursing Home
  • Clinics
  • Others

Key Market Players:

    • APEL Co. Ltd
    • Dragerwerk AG & Co. KGaA
    • Mennen Medical Ltd
    • Micro Lab Instruments
    • Ningbo David Medical Device Co. Ltd
    • Siemens Healthineers AG
    • Micro Labs Instruments
    • AVI Healthcare Pvt Ltd
    • F. Hoffmann-La Roche Ltd.
    • Koninklijke Philips N.V.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BILIRUBIN METERS MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Bench-Top
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Transcutaneous
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: BILIRUBIN METERS MARKET, BY INDICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Indication
  • 5.2. Jaundice
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Hepatitis
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: BILIRUBIN METERS MARKET, BY AGE GROUP

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Age Group
  • 6.2. Neonatal
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Adults
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country

CHAPTER 7: BILIRUBIN METERS MARKET, BY END USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End User
  • 7.2. Hospitals And Nursing Home
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Clinics
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Others
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country

CHAPTER 8: BILIRUBIN METERS MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Product
    • 8.2.3. Market Size and Forecast, By Indication
    • 8.2.4. Market Size and Forecast, By Age Group
    • 8.2.5. Market Size and Forecast, By End User
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Bilirubin Meters Market
      • 8.2.7.1. Market Size and Forecast, By Product
      • 8.2.7.2. Market Size and Forecast, By Indication
      • 8.2.7.3. Market Size and Forecast, By Age Group
      • 8.2.7.4. Market Size and Forecast, By End User
    • 8.2.8. Canada Bilirubin Meters Market
      • 8.2.8.1. Market Size and Forecast, By Product
      • 8.2.8.2. Market Size and Forecast, By Indication
      • 8.2.8.3. Market Size and Forecast, By Age Group
      • 8.2.8.4. Market Size and Forecast, By End User
    • 8.2.9. Mexico Bilirubin Meters Market
      • 8.2.9.1. Market Size and Forecast, By Product
      • 8.2.9.2. Market Size and Forecast, By Indication
      • 8.2.9.3. Market Size and Forecast, By Age Group
      • 8.2.9.4. Market Size and Forecast, By End User
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Product
    • 8.3.3. Market Size and Forecast, By Indication
    • 8.3.4. Market Size and Forecast, By Age Group
    • 8.3.5. Market Size and Forecast, By End User
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. Germany Bilirubin Meters Market
      • 8.3.7.1. Market Size and Forecast, By Product
      • 8.3.7.2. Market Size and Forecast, By Indication
      • 8.3.7.3. Market Size and Forecast, By Age Group
      • 8.3.7.4. Market Size and Forecast, By End User
    • 8.3.8. France Bilirubin Meters Market
      • 8.3.8.1. Market Size and Forecast, By Product
      • 8.3.8.2. Market Size and Forecast, By Indication
      • 8.3.8.3. Market Size and Forecast, By Age Group
      • 8.3.8.4. Market Size and Forecast, By End User
    • 8.3.9. UK Bilirubin Meters Market
      • 8.3.9.1. Market Size and Forecast, By Product
      • 8.3.9.2. Market Size and Forecast, By Indication
      • 8.3.9.3. Market Size and Forecast, By Age Group
      • 8.3.9.4. Market Size and Forecast, By End User
    • 8.3.10. Italy Bilirubin Meters Market
      • 8.3.10.1. Market Size and Forecast, By Product
      • 8.3.10.2. Market Size and Forecast, By Indication
      • 8.3.10.3. Market Size and Forecast, By Age Group
      • 8.3.10.4. Market Size and Forecast, By End User
    • 8.3.11. Spain Bilirubin Meters Market
      • 8.3.11.1. Market Size and Forecast, By Product
      • 8.3.11.2. Market Size and Forecast, By Indication
      • 8.3.11.3. Market Size and Forecast, By Age Group
      • 8.3.11.4. Market Size and Forecast, By End User
    • 8.3.12. Rest of Europe Bilirubin Meters Market
      • 8.3.12.1. Market Size and Forecast, By Product
      • 8.3.12.2. Market Size and Forecast, By Indication
      • 8.3.12.3. Market Size and Forecast, By Age Group
      • 8.3.12.4. Market Size and Forecast, By End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Product
    • 8.4.3. Market Size and Forecast, By Indication
    • 8.4.4. Market Size and Forecast, By Age Group
    • 8.4.5. Market Size and Forecast, By End User
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. Japan Bilirubin Meters Market
      • 8.4.7.1. Market Size and Forecast, By Product
      • 8.4.7.2. Market Size and Forecast, By Indication
      • 8.4.7.3. Market Size and Forecast, By Age Group
      • 8.4.7.4. Market Size and Forecast, By End User
    • 8.4.8. China Bilirubin Meters Market
      • 8.4.8.1. Market Size and Forecast, By Product
      • 8.4.8.2. Market Size and Forecast, By Indication
      • 8.4.8.3. Market Size and Forecast, By Age Group
      • 8.4.8.4. Market Size and Forecast, By End User
    • 8.4.9. Australia Bilirubin Meters Market
      • 8.4.9.1. Market Size and Forecast, By Product
      • 8.4.9.2. Market Size and Forecast, By Indication
      • 8.4.9.3. Market Size and Forecast, By Age Group
      • 8.4.9.4. Market Size and Forecast, By End User
    • 8.4.10. India Bilirubin Meters Market
      • 8.4.10.1. Market Size and Forecast, By Product
      • 8.4.10.2. Market Size and Forecast, By Indication
      • 8.4.10.3. Market Size and Forecast, By Age Group
      • 8.4.10.4. Market Size and Forecast, By End User
    • 8.4.11. South Korea Bilirubin Meters Market
      • 8.4.11.1. Market Size and Forecast, By Product
      • 8.4.11.2. Market Size and Forecast, By Indication
      • 8.4.11.3. Market Size and Forecast, By Age Group
      • 8.4.11.4. Market Size and Forecast, By End User
    • 8.4.12. Rest of Asia-Pacific Bilirubin Meters Market
      • 8.4.12.1. Market Size and Forecast, By Product
      • 8.4.12.2. Market Size and Forecast, By Indication
      • 8.4.12.3. Market Size and Forecast, By Age Group
      • 8.4.12.4. Market Size and Forecast, By End User
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Product
    • 8.5.3. Market Size and Forecast, By Indication
    • 8.5.4. Market Size and Forecast, By Age Group
    • 8.5.5. Market Size and Forecast, By End User
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Bilirubin Meters Market
      • 8.5.7.1. Market Size and Forecast, By Product
      • 8.5.7.2. Market Size and Forecast, By Indication
      • 8.5.7.3. Market Size and Forecast, By Age Group
      • 8.5.7.4. Market Size and Forecast, By End User
    • 8.5.8. Saudi Arabia Bilirubin Meters Market
      • 8.5.8.1. Market Size and Forecast, By Product
      • 8.5.8.2. Market Size and Forecast, By Indication
      • 8.5.8.3. Market Size and Forecast, By Age Group
      • 8.5.8.4. Market Size and Forecast, By End User
    • 8.5.9. South Africa Bilirubin Meters Market
      • 8.5.9.1. Market Size and Forecast, By Product
      • 8.5.9.2. Market Size and Forecast, By Indication
      • 8.5.9.3. Market Size and Forecast, By Age Group
      • 8.5.9.4. Market Size and Forecast, By End User
    • 8.5.10. Rest of LAMEA Bilirubin Meters Market
      • 8.5.10.1. Market Size and Forecast, By Product
      • 8.5.10.2. Market Size and Forecast, By Indication
      • 8.5.10.3. Market Size and Forecast, By Age Group
      • 8.5.10.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. APEL Co. Ltd
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. Dragerwerk AG And Co. KGaA
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. Mennen Medical Ltd
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Micro Lab Instruments
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. Ningbo David Medical Device Co. Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Siemens Healthineers AG
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. Micro Labs Instruments
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. AVI Healthcare Pvt Ltd
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. Koninklijke Philips N.V.
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments